PD-L1 Testing & Therapeutics Market to Reach US$ 159.84B by 2033, Driven by Immuno-Oncology & Precision Medicine
North America leads adoption; Asia-Pacific fastest-growing with PD-L1 inhibitors, bispecific antibodies, and biomarker-driven therapies. AUSTIN, TX, UNITED STATES, October 16, 2025 /EINPresswire.com/ -- The Global PD-L1 Testing and Therapeutics Market, …